Date: 2017-11-09
Type of information: Nomination
Compound: head of technical operations and manufacturing
Company: Sangamo Therapeutics (USA - CA)
Therapeutic area: Rare diseases - Genetic diseases - Technology - Services
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On November 9, 2017 , Sangamo Therapeutics announced the appointment of Andy Ramelmeier, PhD, as Senior Vice President, Head of Technical Operations and Manufacturing. Dr. Ramelmeier has more than 25 years of leadership experience in biopharmaceutical manufacturing, process development and technical operations at Merck, Johnson & Johnson, BioMarin and, most recently, Portola Pharmaceuticals. He received a Bachelor of Science degree in Chemical Engineering from Johns Hopkins University and a PhD in Chemical Engineering from University of California, Berkeley. Dr. Ramelmeier will join Sangamo full time effective January 1, 2018.
Financial terms:
Latest news:
Is general: Yes
